Elanco Animal Health Incorporated
NYSE:ELAN
11.96 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| 338 | -1,231 | -78 | -472 | -560.1 | 67.9 | 86.5 | -310.7 | -47.9 | -210.8 |
| Depreciation & Amortization
| 662 | 694 | 682 | 716 | 516.9 | 314.5 | 296 | 318.4 | 254.4 | 236.9 |
| Deferred Income Tax
| -112 | -80 | -57 | -154 | -124.8 | 0.1 | -60.7 | -13.4 | -5.9 | -76.2 |
| Stock Based Compensation
| 55 | 46 | 59 | 66 | 47 | 49.4 | 26 | 25 | 20.4 | 13.4 |
| Change In Working Capital
| 149 | -300 | -462 | -87 | 165.7 | -227.7 | -29.2 | 53.5 | -169.4 | -15.7 |
| Accounts Receivables
| 12 | -40 | 14 | -3 | 14 | -172.4 | -122 | 48.4 | -80.7 | -94.6 |
| Inventory
| 44 | -160 | -269 | 27 | -94.7 | -33.1 | -20.1 | -39 | -89.1 | 14.9 |
| Accounts Payables
| 82 | -94 | -98 | -120 | 369.3 | -29.2 | 116.1 | -8.4 | 37.1 | 116.4 |
| Other Working Capital
| 11 | -6 | -109 | 9 | -122.9 | 7 | -3.2 | 52.5 | -36.7 | -52.4 |
| Other Non Cash Items
| -551 | 1,142 | 308 | 414 | -86.4 | 19.9 | 168.7 | 101 | 104.3 | 59 |
| Operating Cash Flow
| 541 | 271 | 452 | 483 | -41 | 224.1 | 487.3 | 173.8 | 155.9 | 6.6 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -147 | -140 | -184 | -197 | -310.9 | -197.4 | -134.5 | -98.6 | -110.3 | -100.1 |
| Acquisitions Net
| 0 | -19 | 13 | -342 | -4,566.6 | -32.8 | 9.4 | -882.1 | -45 | -5,283.1 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | -103.6 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 32.7 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 1,305 | -10 | -8 | 9 | 169.2 | -4.6 | 7.5 | 16.1 | -26.8 | 387.8 |
| Investing Cash Flow
| 1,158 | -169 | -179 | -530 | -4,779.2 | -234.8 | -127 | -964.6 | -182.1 | -4,995.4 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -1,475 | -77 | -517 | 177 | 3,852 | -121 | 2,492.5 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 1,219.9 | 0 | 1,659.7 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -17 | -6 | -32 | 33 | -118.1 | -183.8 | -2,527.7 | 847.5 | -149.6 | 5,353.2 |
| Financing Cash Flow
| -1,492 | -83 | -549 | 210 | 4,953.9 | -304.8 | -35.2 | 847.5 | -149.6 | 5,353.2 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| -91 | -12 | -17 | -31 | 26.6 | -16.9 | 29 | 7.9 | -26 | -19.8 |
| Net Change In Cash
| 116 | 7 | -293 | 132 | 160.3 | -332.4 | 354.1 | 64.6 | -201.8 | 344.6 |
| Cash At End Of Period
| 468 | 352 | 345 | 638 | 505.4 | 345.1 | 677.5 | 323.4 | 258.8 | 460.6 |